Dr A J Binder, MD in Metairie, LA - Medicare Orthopedic Surgery

Dr A J Binder, MD is a medicare enrolled "Orthopaedic Surgery" physician in Metairie, Louisiana. He went to Tulane University School Of Medicine and graduated in 1986 and has 38 years of diverse experience with area of expertise as Orthopedic Surgery. He is a member of the group practice Crescent City Orthopedics Llc and his current practice location is 4720 S I 10 Service Rd W, Suite 301, Metairie, Louisiana. You can reach out to his office (for appointments etc.) via phone at (504) 885-8225.

Dr A J Binder is licensed to practice in Louisiana (license number 018738) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1235130931.

Contact Information

	Dr A J Binder, MD
	4720 S I 10 Service Rd W, Suite 301, Metairie, LA 70001-7404
	(504) 885-8225
	(504) 885-7642

Physician's Profile

Full Name	Dr A J Binder
Gender	Male
Speciality	Orthopedic Surgery
Experience	38 Years
Location	4720 S I 10 Service Rd W, Metairie, Louisiana
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr A J Binder attended and graduated from Tulane University School Of Medicine in 1986

NPI Data:

NPI Number: 1235130931
Provider Enumeration Date: 08/03/2005
Last Update Date: 01/15/2008

Medicare PECOS Information:

PECOS PAC ID: 3072694975
Enrollment ID: I20080402000502

Medical Identifiers

Medical identifiers for Dr A J Binder such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1235130931	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207X00000X	Orthopaedic Surgery	018738 (Louisiana)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Tulane Medical Center	New orleans, LA	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Crescent City Orthopedics Llc	4385823913	8

News Archive

Loss of taste in COVID-19 is highly variable by geographic region

Even as the COVID-19 pandemic spreads in different parts of the world, scientists are still attempting to define the characteristic signs and symptoms that are useful in diagnosing the disease. This is essential knowledge to help contain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission. Especially when it comes to diagnosing symptomatic or mild cases of COVID-19, such research could hold the key to identifying more people and preventing viral spread.

MiMedx' HydroFix Vaso Shield receives FDA clearance for additional thicknesses and sizes

MiMedx Group, Inc., an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today that it has received notification by the FDA that the Company's proprietary device, HydroFix™ Vaso Shield, has received 510(k) clearance for additional thicknesses and sizes.

Arena third quarter net loss increases to $36.3 million

Arena Pharmaceuticals, Inc. today reported financial results for the third quarter ended September 30, 2010. Arena also reported earlier today top-line results from its lorcaserin Phase 3 BLOOM-DM (Behavioral modification and Lorcaserin for Overweight and Obesity Management in Diabetes Mellitus) trial.

New tool combines drugs to target kinase dependency in cancer

Targeted therapies attack a cancer's genetic sensitivities. However, it can be difficult to discover the genetics driving a patient's cancer, and the effects of drugs designed to target a genetic abnormality often go beyond their intended target alone. The result is threefold: sometimes a drug is prescribed to treat a target that proves to be irrelevant to the disease, sometimes an existing drug could be used to treat a cancer for which there is no approved targeted therapy, and sometimes a combination of targeted treatments could be used to simultaneously silence more than one genetic cause of a patient's cancer.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr A J Binder allows following entities to bill medicare on his behalf.

Entity Name	A. Jay Binder, M.d., A Medical Corporation
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1578749875 PECOS PAC ID: 3375620271 Enrollment ID: O20080402000510

News Archive

Loss of taste in COVID-19 is highly variable by geographic region

MiMedx' HydroFix Vaso Shield receives FDA clearance for additional thicknesses and sizes

Arena third quarter net loss increases to $36.3 million

New tool combines drugs to target kinase dependency in cancer

Entity Name	Crescent City Orthopedics Llc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1215238902 PECOS PAC ID: 4385823913 Enrollment ID: O20110127000828

Loss of taste in COVID-19 is highly variable by geographic region

MiMedx' HydroFix Vaso Shield receives FDA clearance for additional thicknesses and sizes

Arena third quarter net loss increases to $36.3 million

New tool combines drugs to target kinase dependency in cancer

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr A J Binder is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr A J Binder, MD 4720 S I 10 Service Rd W, Suite 301, Metairie, LA 70001-7404 Ph: (504) 885-8225	Dr A J Binder, MD 4720 S I 10 Service Rd W, Suite 301, Metairie, LA 70001-7404 Ph: (504) 885-8225

News Archive

Loss of taste in COVID-19 is highly variable by geographic region

MiMedx' HydroFix Vaso Shield receives FDA clearance for additional thicknesses and sizes

Arena third quarter net loss increases to $36.3 million

New tool combines drugs to target kinase dependency in cancer

Orthopaedic Surgery Doctors in Metairie, LA

Dr. David W. Aiken, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4224 Houma Blvd, Suite 650, Metairie, LA 70006 Phone: 504-456-5152 Fax: 504-456-5019
Dr. Warren Roger Bourgeois Iii, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3939 Houma Blvd, Suite 18, Metairie, LA 70006 Phone: 504-455-0093 Fax: 504-454-3964
Dr. Matko Milicic, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 312 Friedrichs Ave, Metairie, LA 70005 Phone: 504-832-5940
John G Burvant, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3939 Houma Blvd, Suite 21, Metairie, LA 70006 Phone: 504-885-6464 Fax: 504-885-6414
Russell Levy, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 4905 Folse Dr, Metairie, LA 70006 Phone: 504-455-4883
Ryan Charles Roubion, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3001 Division St Ste 204, Metairie, LA 70002 Phone: 504-541-5800 Fax: 504-541-5801
Dr. Bobby L Mimeles, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 4720 S I 10 Service Rd W, Suite 301, Metairie, LA 70001 Phone: 504-885-8225 Fax: 504-885-7642

Dr A J Binder, MD - Medicare Orthopedic Surgery in Metairie, LA

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Loss of taste in COVID-19 is highly variable by geographic region

MiMedx' HydroFix Vaso Shield receives FDA clearance for additional thicknesses and sizes

Arena third quarter net loss increases to $36.3 million

New tool combines drugs to target kinase dependency in cancer

Medicare Reassignments

Loss of taste in COVID-19 is highly variable by geographic region

MiMedx' HydroFix Vaso Shield receives FDA clearance for additional thicknesses and sizes

Arena third quarter net loss increases to $36.3 million

New tool combines drugs to target kinase dependency in cancer

Loss of taste in COVID-19 is highly variable by geographic region

MiMedx' HydroFix Vaso Shield receives FDA clearance for additional thicknesses and sizes

Arena third quarter net loss increases to $36.3 million

New tool combines drugs to target kinase dependency in cancer

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Loss of taste in COVID-19 is highly variable by geographic region

MiMedx' HydroFix Vaso Shield receives FDA clearance for additional thicknesses and sizes

Arena third quarter net loss increases to $36.3 million

New tool combines drugs to target kinase dependency in cancer

Orthopaedic Surgery Doctors in Metairie, LA